Vibrio cholerae is the causative agent of the acute diarrheal disease of cholera. Innate immune responses to V. cholerae are not a major cause of cholera pathology, which is characterized by severe, watery diarrhea induced by the action of cholera toxin. Innate responses may, however, contribute to resolution of infection and must be required to initiate adaptive responses after natural infection and oral vaccination. Here we investigated whether a well-established infant mouse model of cholera can be used to observe an innate immune response. We also used a vaccination model in which immunized dams protect their pups from infection through breast milk antibodies to investigate innate immune responses after V. cholerae infection for pups suckled by an immune dam. At the peak of infection, we observed neutrophil recruitment accompanied by induction of KC, macrophage inflammatory protein 2 (MIP-2), NOS-2, interleukin-6 (IL-6), and IL-17a. Pups suckled by an immunized dam did not mount this response. Accessory toxins RtxA and HlyA played no discernible role in neutrophil recruitment in a wild-type background. The innate response to V. cholerae deleted for cholera toxin-encoding phage (CTX) and part of rtxA was significantly reduced, suggesting a role for CTX-carried genes or for RtxA in the absence of cholera toxin (CTX). Two extracellular V. cholerae DNases were not required for neutrophil recruitment, but DNase-deficient V. cholerae caused more clouds of DNA in the intestinal lumen, which appeared to be neutrophil extracellular traps (NETs), suggesting that V. cholerae DNases combat NETs. Thus, the infant mouse model has hitherto unrecognized utility for interrogating innate responses to V. cholerae infection.
Vibrio cholerae is the causative agent of cholera, which remains endemic in many regions of Africa and Asia (1). Sporadic outbreaks can devastate immunologically naïve populations, such as occurred in Haiti in 2010 (2). The O1 serogroup and, to a lesser degree, O139 are the major causes of cholera, and El Tor is currently the circulating O1 biotype (1). Cholera toxin (CTX), encoded by a lysogenic phage (3), is the major cause of the severe secretory diarrhea that is typical of cholera. Without rehydration therapy, cholera results in 25 to 50% mortality, but if treated, cholera will resolve in most patients (4). Unlike diseases such as shigellosis and Salmonella-induced gastroenteritis (5, 6), the pathology of cholera is not immune driven. However, innate immune responses have been observed in cholera patients during the acute phase of infection (7) and likely play a direct and/or indirect role in the resolution of disease. The majority of individuals who survive a bout of cholera will become immune to subsequent infection for at least 3 years (8-10), and some aspects of the observed innate immune response must be required to initiate this protective immunity.Many live attenuated vaccine candidate strains of V. cholerae have been developed in which ctxA, the gene encoding the catalytic subunit of cholera tox...